Direct Access Web Page for the OncoAlert Colloquium
February 3-9, 2025
Access to the live feed is password-protected, and registration is required.
Registration Link: https://buff.ly/4hcLX5C
A 100% virtual, week-long meeting highlighting the most important developments in oncology each year, delivered by some of the world’s leading oncologists in a multidisciplinary format.
The Colloquium is free for oncology professionals and cancer stakeholders, but registration is required for participation.
Presentations will take place from February 3-9, 2025
A LIVE CHAT function will be available during each session, enabling real-time interaction with presenters. To participate, you'll need to create a username and log in using your registration password. All presentations and chat discussions will be accessible for viewing in the video windows below.
Language: The live feed will initially be without captions. However, captions will be available in the on-demand content. The original language of the sessions will be in English, with Spanish and French captions added shortly afterward.
The Colloquium is held in partnership with:
**The Colloquium is partly supported by Pfizer and Roche, with all presentations made independently by the presenters, without any industry influence on the topics or content.
The Colloquium is free for oncology professionals and cancer stakeholders, but registration is required for participation.
Presentations will take place from February 3-9, 2025
A LIVE CHAT function will be available during each session, enabling real-time interaction with presenters. To participate, you'll need to create a username and log in using your registration password. All presentations and chat discussions will be accessible for viewing in the video windows below.
Language: The live feed will initially be without captions. However, captions will be available in the on-demand content. The original language of the sessions will be in English, with Spanish and French captions added shortly afterward.
The Colloquium is held in partnership with:
- European Society of Surgical Oncology (ESSO)
- European Society of Gynecological Oncology (ESGO)
- International Society of Geriatric Oncology (SIOG)
- Multidisciplinary Association of Supportive Care in Cancer (MASCC)
- Advanced Prostate Cancer Consensus Conference
- GUARD Consortium
- ABC Global Alliance
- KidneyCan
- GU Cast
- Belgian Society of Medical Oncology (BSMO)
**The Colloquium is partly supported by Pfizer and Roche, with all presentations made independently by the presenters, without any industry influence on the topics or content.
Contact Us with Questions about the Colloquium
🔻ACCESS COLLOQUIUM HERE🔻
LIVE Chat Box will appear to the Right of the Screen & Requires login
Day One: GU Cancers
WATCH NOW ON DEMAND!!
Day Two: Lung Cancers
WATCH NOW ON DEMAND!!
Day Three: Breast Cancer
WATCH NOW ON DEMAND!!
Day Four: GI Cancers
WATCH NOW ON DEMAND!!
Day Five: Gynecologic Cancers
Feb 7, 2025 (12 noon EST)
Day Six: Hematology, Sarcoma & Lymphoma
Feb 8, 2025 (12 noon EST)
Day Seven: How I Treat Cancer...When I don't Have the Treatment
Feb 9, 2025 (12 noon EST)
All presentations will be available on-demand for registered attendees. Thank you for your support!
🔻Colloquium Schedule🔻
DAY 1 (GU Oncology)
February 3, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
Kidney Cancer (15 min) Dr. Vincent Xu (KidneyCan Session) Dana Farber Cancer Institute, USA
Bladder Cancer (15 min) Dr Petros Grivas of Fred Hutch Cancer Center, USA
Prostate Cancer (15 min) Dr. Silke Gillessen (APCCC Session) of Advanced Prostate Cancer Consensus, Switzerland
Urology in 2024 & Controversial Topics (15 min) Drs Declan Murphy & Renu Eapen (GU Cast Session) Peter MacCallum Cancer Centre, Australia
GU Radiotherapy (15 min) Dr Sean McBride of Memorial Sloan Kettering,USA
Clinical Trials that Have Changed the Landscape in 2024 in GU Oncology (15 min) Dr. Maria Jose Juan Fita and Dr. Elena Sevillano for the GUARD Consortium Session
GU patient advocate perspective (5 min) Mr. Bryan Lewis (KidneyCan Session) President & Co-Founder of KidneyCan, USA
DAY 2 (Thoracic Oncology)
February 4, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
NSCLC (early) (15 min) Dr. Gilberto Lopes of Sylvester Cancer Center, USA
NSCLC Advanced (15 min) Dr. Charu Aggarwal of Penn Medicine, USA
SCLC and Mesothelioma (15 min) Dr. Jarushka Naidoo of Beaumont Hospital Dublin, Ireland
Lung Cancer Radiotherapy (15 min) Dr. Henning Willers and Dr. Katie Keane of Massachusetts General Hospital, USA
Lung Cancer Pathology & Diagnostics (15 min) Dr. Umberto Malapelle of University of Naples, Italy
MASCC Sessions:
Mucositis (15 min) preclinical aspects and how they impact on a clinical approach: DrsPaolo Bossi & Hannah Wardill, Italy & Australia
ADC toxicities (15 min) Dr. Myriam Lustberg of Yale Cancer Center
DAY 3 (Breast Cancer)
February 5, 2025 (Start 6pm CET 12 noon EST) 2hrs 55 min in Total
Advanced Hormone Receptor Positive HER2 positive breast cancer (15 min) Dr. Erika Hamilton of Sarah Cannon Cancer Center, USA
HER2 Metastatic Breast Cancer (15 min) Dr. Stephanie Graff of Brown university Health Cancer Insitute, USA
Advanced Triple negative breast cancer (15 min) Dr. Hope Rugo of University of California San Francisco, USA
Early hormone receptor positive Her2 positive breast cancer & HER2 Early Breast Cancer (15 min) Dr. Evandro de Azambuja (BSMO) President of Belgian Society of Medical Oncology, Belgium
Early Triple negative breast cancer (15 min) Dr. Kevin Punie (BSMO) Vice President of Belgian Society of Medical Oncology, Belgium
ER+ Early Breast Cancer (15 min) Dr. Maryam Lustberg, Yale Cancer Center, USA
Fertily Preservation (15 min) Dr. Matteo Lambertini of University of Genova, Italy
Surgical Breast Cancer Oncology (15 min) Dr. Jose Volders of Diakonessenhuis, Netherlands
Session on Breast Cancer Subtypes (Brain Mets) Dr. Fatima Cardoso (ABC Session) of the ABC Global Alliance
Breast Cancer Radiotherapy (15 min) Dr. Icro Meatini of University of Florence, Italy
Breast Cancer Pathology & Diagnostics (15 min) Dr. Roberto Salgado of AZ Middelheim, Belgium
The Patient advocate perspective (5) Ms Christine Hodgdon of GRASP, USA for ABC Global Alliance
The Patient advocate perspective (5) Ms Tanja Spanic of Slovenia
DAY 4 (GI Oncology)
February 6, 2025 (Start 6pm CET 12 noon EST) 1hr 45 min in Total
Colon Cancer and Anal (15 min) Dr. Cathy Eng of Vanderbilt-Ingram Cancer Center, USA
Gastric, Esophageal & Liver (15 min) Dr. Sharlene Gill of VC Cancer at Vancouver, Canada
Pancreatic Cancer (15 min) Dr. Ben Westphalen of University of Munich, Germany
GI Surgery Upper (ESSO Session) (15 min) Dr. Laura Lorenzon of Policlinico Universitario Agostino Gemelli, Italy
GI Surgery Lower (ESSO Session) (15 min) Dr. Jim Khan of HCA Healthcare, UK
GI Radiotherapy (15 min) Dr. Nina Sanford of UT Southwestern, USA
The Patient Advocate Perspective (5 min) Ms. Allison Rosen of American Cancer Society
Day 5 (Gynecological Oncology)
February 7, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
Cervical Cancer: Dr. Nicolo Bizzarri (Surgical) of Fondazione Policlinico Universitario A. Gemelli,Italy and Dr. Domenica Lorusso (Medical) of Humanitas Hospital San Pio X, Milan, Italy
Endometrial Cancer: Dr. Aleksandra Strojna (Surgical) of Pomeranian Medical University, Poland and Dr. Annamaria Ferrero (Medical) of Ospedale Ordine Mauriziano di Torino, Italy
Ovarian Cancer: Dr. Alejandra Martinez (Surgical) of nstitut Universitaire du Cancer de Toulouse, France and
Dr. Isabelle Ray-Coquard (Medical) of Cancer Research Center of Lyon, France
Vaginal and Vulvar Cancer: Dr. Christina Fotopoulou (Vaginal Surgical)of Imperial College London, UK , Dr. Maaike Oonk (Vulvar Surgical), of University of Gronengin, Netherlands and Dr. Cyrus Chargari (Medical) of Pitié Salpêtrière University Hospital
Patient Advocate: Ms. Kim Hulscher, ENGAGe Co-Chair of Netherlands
Day 6 (Hematology)
February 8, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
Leukemias
CLL (15 min) Dr. Raul Cordoba Mascuñano of University Hospital Fundacion Jimenez Diaz, Spain
AML (15 min) Dr. Fadi Haddad of MD Anderson Cancer Center, USA
Lymphoma (15 min) Dr. Jason Westin of MD Anderson Cancer Center, USa
Myeloma (15 min) Dr. Al-Ola Abdallah of Kansas Medical Center, USA
Sarcoma (15 min) Dr. Jonathan Trent of Sylvester Cancer Center, USA
SIOG Sessions in Geriatric Oncology
1 Dr. Enrique Soto (15 min) University of Colorado, USA
2 Dr. Melissa Loh (15 min) Wilmot Cancer Center, USA
Melanoma Session (15 min) Dr. Allison Betof Warner of Stanford Medicine, USA
Day 7 (How I Treat Cancer When I dont have access to the Treatment) 1hr 30 min in Total
February 9, 2025 (Start 6pm CET 12 noon EST)
Lung Cancer (15-20 min)
Dr. Rogelio Velasco of Philippines
Breast Cancer (15-20 min)
Dr. Jose Fernando Prado Moura of Brazil
GU Cancer (15-20 min)
Dr. Natalia Gandur of Argentina
GI Cancer (15-20 min)
Dr. Noha Fouad Mohamed Rashad of Egypt
GynOnc (15-20 min)
Dr. Arun Shahi of Nepal
February 3, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
Kidney Cancer (15 min) Dr. Vincent Xu (KidneyCan Session) Dana Farber Cancer Institute, USA
Bladder Cancer (15 min) Dr Petros Grivas of Fred Hutch Cancer Center, USA
Prostate Cancer (15 min) Dr. Silke Gillessen (APCCC Session) of Advanced Prostate Cancer Consensus, Switzerland
Urology in 2024 & Controversial Topics (15 min) Drs Declan Murphy & Renu Eapen (GU Cast Session) Peter MacCallum Cancer Centre, Australia
GU Radiotherapy (15 min) Dr Sean McBride of Memorial Sloan Kettering,USA
Clinical Trials that Have Changed the Landscape in 2024 in GU Oncology (15 min) Dr. Maria Jose Juan Fita and Dr. Elena Sevillano for the GUARD Consortium Session
GU patient advocate perspective (5 min) Mr. Bryan Lewis (KidneyCan Session) President & Co-Founder of KidneyCan, USA
DAY 2 (Thoracic Oncology)
February 4, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
NSCLC (early) (15 min) Dr. Gilberto Lopes of Sylvester Cancer Center, USA
NSCLC Advanced (15 min) Dr. Charu Aggarwal of Penn Medicine, USA
SCLC and Mesothelioma (15 min) Dr. Jarushka Naidoo of Beaumont Hospital Dublin, Ireland
Lung Cancer Radiotherapy (15 min) Dr. Henning Willers and Dr. Katie Keane of Massachusetts General Hospital, USA
Lung Cancer Pathology & Diagnostics (15 min) Dr. Umberto Malapelle of University of Naples, Italy
MASCC Sessions:
Mucositis (15 min) preclinical aspects and how they impact on a clinical approach: DrsPaolo Bossi & Hannah Wardill, Italy & Australia
ADC toxicities (15 min) Dr. Myriam Lustberg of Yale Cancer Center
DAY 3 (Breast Cancer)
February 5, 2025 (Start 6pm CET 12 noon EST) 2hrs 55 min in Total
Advanced Hormone Receptor Positive HER2 positive breast cancer (15 min) Dr. Erika Hamilton of Sarah Cannon Cancer Center, USA
HER2 Metastatic Breast Cancer (15 min) Dr. Stephanie Graff of Brown university Health Cancer Insitute, USA
Advanced Triple negative breast cancer (15 min) Dr. Hope Rugo of University of California San Francisco, USA
Early hormone receptor positive Her2 positive breast cancer & HER2 Early Breast Cancer (15 min) Dr. Evandro de Azambuja (BSMO) President of Belgian Society of Medical Oncology, Belgium
Early Triple negative breast cancer (15 min) Dr. Kevin Punie (BSMO) Vice President of Belgian Society of Medical Oncology, Belgium
ER+ Early Breast Cancer (15 min) Dr. Maryam Lustberg, Yale Cancer Center, USA
Fertily Preservation (15 min) Dr. Matteo Lambertini of University of Genova, Italy
Surgical Breast Cancer Oncology (15 min) Dr. Jose Volders of Diakonessenhuis, Netherlands
Session on Breast Cancer Subtypes (Brain Mets) Dr. Fatima Cardoso (ABC Session) of the ABC Global Alliance
Breast Cancer Radiotherapy (15 min) Dr. Icro Meatini of University of Florence, Italy
Breast Cancer Pathology & Diagnostics (15 min) Dr. Roberto Salgado of AZ Middelheim, Belgium
The Patient advocate perspective (5) Ms Christine Hodgdon of GRASP, USA for ABC Global Alliance
The Patient advocate perspective (5) Ms Tanja Spanic of Slovenia
DAY 4 (GI Oncology)
February 6, 2025 (Start 6pm CET 12 noon EST) 1hr 45 min in Total
Colon Cancer and Anal (15 min) Dr. Cathy Eng of Vanderbilt-Ingram Cancer Center, USA
Gastric, Esophageal & Liver (15 min) Dr. Sharlene Gill of VC Cancer at Vancouver, Canada
Pancreatic Cancer (15 min) Dr. Ben Westphalen of University of Munich, Germany
GI Surgery Upper (ESSO Session) (15 min) Dr. Laura Lorenzon of Policlinico Universitario Agostino Gemelli, Italy
GI Surgery Lower (ESSO Session) (15 min) Dr. Jim Khan of HCA Healthcare, UK
GI Radiotherapy (15 min) Dr. Nina Sanford of UT Southwestern, USA
The Patient Advocate Perspective (5 min) Ms. Allison Rosen of American Cancer Society
Day 5 (Gynecological Oncology)
February 7, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
Cervical Cancer: Dr. Nicolo Bizzarri (Surgical) of Fondazione Policlinico Universitario A. Gemelli,Italy and Dr. Domenica Lorusso (Medical) of Humanitas Hospital San Pio X, Milan, Italy
Endometrial Cancer: Dr. Aleksandra Strojna (Surgical) of Pomeranian Medical University, Poland and Dr. Annamaria Ferrero (Medical) of Ospedale Ordine Mauriziano di Torino, Italy
Ovarian Cancer: Dr. Alejandra Martinez (Surgical) of nstitut Universitaire du Cancer de Toulouse, France and
Dr. Isabelle Ray-Coquard (Medical) of Cancer Research Center of Lyon, France
Vaginal and Vulvar Cancer: Dr. Christina Fotopoulou (Vaginal Surgical)of Imperial College London, UK , Dr. Maaike Oonk (Vulvar Surgical), of University of Gronengin, Netherlands and Dr. Cyrus Chargari (Medical) of Pitié Salpêtrière University Hospital
Patient Advocate: Ms. Kim Hulscher, ENGAGe Co-Chair of Netherlands
Day 6 (Hematology)
February 8, 2025 (Start 6pm CET 12 noon EST) 1 hr 45 min in Total
Leukemias
CLL (15 min) Dr. Raul Cordoba Mascuñano of University Hospital Fundacion Jimenez Diaz, Spain
AML (15 min) Dr. Fadi Haddad of MD Anderson Cancer Center, USA
Lymphoma (15 min) Dr. Jason Westin of MD Anderson Cancer Center, USa
Myeloma (15 min) Dr. Al-Ola Abdallah of Kansas Medical Center, USA
Sarcoma (15 min) Dr. Jonathan Trent of Sylvester Cancer Center, USA
SIOG Sessions in Geriatric Oncology
1 Dr. Enrique Soto (15 min) University of Colorado, USA
2 Dr. Melissa Loh (15 min) Wilmot Cancer Center, USA
Melanoma Session (15 min) Dr. Allison Betof Warner of Stanford Medicine, USA
Day 7 (How I Treat Cancer When I dont have access to the Treatment) 1hr 30 min in Total
February 9, 2025 (Start 6pm CET 12 noon EST)
Lung Cancer (15-20 min)
Dr. Rogelio Velasco of Philippines
Breast Cancer (15-20 min)
Dr. Jose Fernando Prado Moura of Brazil
GU Cancer (15-20 min)
Dr. Natalia Gandur of Argentina
GI Cancer (15-20 min)
Dr. Noha Fouad Mohamed Rashad of Egypt
GynOnc (15-20 min)
Dr. Arun Shahi of Nepal